Where does hypnotherapy stand in the management of irritable bowel syndrome? A systematic review

Journal of Alternative and Complementary Medicine

Volumn 12, Issue 6, 2006, Pages 517-527

  Gholamrezaei, Ali ^a,b   Ardestani, Samaneh Khanpour ^a   Emami, Mohammad Hasan ^b,c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Poursina Hakim Research Institute   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ANXIETY DISORDER; ARTICLE; CHRONIC PAIN; DEPRESSION; GASTROINTESTINAL DISEASE; HUMAN; HYPNOSIS; IRRITABLE COLON; MEDICAL LITERATURE; MEDLINE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; SYMPTOM; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

CONTROLLED CLINICAL TRIALS; HUMANS; HYPNOSIS; IRRITABLE BOWEL SYNDROME; PATIENT COMPLIANCE; PLACEBOS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 33750627311     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2006.12.517     Document Type: Article

References (48)

1. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999;45(Suppl 2):II43-II47.
2. Mitchell CM, Drossman DA. Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology 1987;92(5 Pt 1)1282-1284.
3. Harvey RF, Salih SY, Read AE. Organic and functional disorders in 2000 gastroenterology outpatients. Lancet 1983; 1(8325):632-634.
4. Talley NJ. Pharmacologic therapy for the irritable bowel syndrome. Am J Gastroenterol 2003;98:750-758.
5. Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: Long-term prognosis and the physician-patient interaction. Ann Intern Med 1995;122:107-112.
6. Levy RL, Von Korff M, Whitehead WE, et al. Costs of care for irritable bowel syndrome patients in a health maintenance organization. Am J Gastroenterol 2001;96:3122-3129.
7. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-1580.
8. Simren M, Ringstrom G, Bjornsson ES, Abrahamsson H. Treatment with hypnotherapy reduces the sensory and motor component of the gastrocolonic response in irritable bowel syndrome. Psychosom Med 2004;66:233-238
9. Mulak A, Bonaz B. Irritable bowel syndrome: A model of the brain-gut interactions. Med Sci Monit 2004;10:RA55-RA62.
10. Bonaz B, Baciu M, Papillon E, et al. Central processing of rectal pain in patients with irritable bowel syndrome: An fMRI study. Am J Gastroenterol 2002;97:654-661.
11. Herschbach P, Henrich G, von Rad M. Psychological factors in functional gastrointestinal disorders: Characteristics of the disorder or of the illness behavior? Psychosom Med 1999;61:148-153.
12. Mayer EA, Naliboff BD, Chang L, Coutinho SV. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2001;280:G519-G524.
13. Walker EA, Roy-Byrne PP, Katon WJ. Irritable bowel syndrome and psychiatric illness. Am J Psychiatry 1990;147:565-572.
14. Langeluddecke PM. Psychological aspects of irritable bowel syndrome. Aust N Z J Psychiatry 1985;19(3):218-226.
15. Talley NJ, Owen BK, Boyce P, Paterson K. Psychological treatments for irritable bowel syndrome: A critique of controlled treatment trials. Am J Gastroenterol 1996;91:277-283.
16. Vidakovic-Vukic M. Hypnotherapy in the treatment of irritable bowel syndrome: methods and results in Amsterdam. Scand J Gastroenterol Suppl 1999;230:49-51.
17. Houghton LA, Heyman DJ, Whorwell PJ. Symptomatology, quality of life and economic features of irritable bowel syndrome-the effect of hypnotherapy. Aliment Pharmacol Ther 1996;10:91-95.
18. Prior A, Colgan SM, Whorwell PJ. Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome. Gut 1990;31:896-898.
19. Harvey RF, Hinton RA, Gunary RM, Barry RE. Individual and group hypnotherapy in treatment of refractory irritable bowel syndrome. Lancet 1989;1:424-425.
20. Whorwell PJ, Prior A, Faragher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet 1984;2:1232-1234.
21. Whorwell PJ, Prior A, Colgan SM. Hypnotherapy in severe irritable bowel syndrome: Further experience. Gut 1987;28:423-425.
22. Palsson OS, Turner MJ, Johnson DA, et al. Hypnosis treatment for severe irritable bowel syndrome: Investigation of mechanism and effects on symptoms (Study 1). Dig Dis Sci 2002;47:2605-2614.
23. Palsson OS, Turner MJ, Johnson DA, et al. Hypnosis treatment for severe irritable bowel syndrome: Investigation of mechanism and effects on symptoms (Study 2). Dig Dis Sci 2002;47:2605-2614.
24. Galovski TE, Blanchard EB. The treatment of irritable bowel syndrome with hypnotherapy. Appl Psychophysiol Biofeedback 1998;23:219-232.
25. Gonsalkorale WM, Toner BB, Whorwell PJ. Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome. J Psychosom Res 2004;56:271-278.
26. Lea R, Houghton LA, Calvert EL, et al. Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2003;17:635-642.
27. Gonsalkorale WM, Miller V, Afzal A, Whorwell PJ. Long term benefits of hypnotherapy for irritable bowel syndrome. Gut 2003;52:1623-1629.
28. Forbes A, MacAuley S, Chiotakakou-Faliakou E. Hypnotherapy and therapeutic audiotape: Effective in previously unsuccessfully treated irritable bowel syndrome? Int J Colorectal Dis 2000;15(5-6):328-334.
29. Galovski TE, Blanchard EB. Hypnotherapy and refractory irritable bowel syndrome: A single case study. Am J Clin Hypn 2002;45:31-37.
30. Zimmerman J. Cleaning up the river: A metaphor for functional digestive disorders. Am J Clin Hypn 2003;45(4):353-359.
31. Talley NJ, Nyren O, Drossman DA. The irritable bowel syndrome: Toward optimal design of controlled treatment trials. Gastroenterol 1993;6:189-211.
32. Veldhuyzen van Zanten SJ, Talley NJ, Bytzer P, et al. Design of treatment trials for functional gastrointestinal disorders. Gut 1999;45(suppl2):II69- II77.
33. Gonsalkorale WM, Houghton LA, Whorwell PJ. Hypnotherapy in irritable bowel syndrome: A large-scale audit of a clinical service with examination of factors influencing responsiveness. Am J Gastroenterol 2002;97(4):954-961.
34. Fletcher RH, Fletcher SW, Wagner EH. Clinical Epidemiology: The Essentials, 2nd ed. Baltimore: Williams & Wilkins, 1988.
35. Spiller RC. Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials. Am J Med 1999;107(5A):91S-97S.
36. Talley NJ. Evaluation of drug treatment in irritable bowel syndrome. Br J Clin Pharmacol 2003;56(4):362-369.
37. Borkovec TD, Nau SD. Credibility of analogue therapy rationales. J Behav Ther Exp Psychiatry 1972;3:257-260.
38. Kirsch I. The placebo effect and the cognitive-behavioural revolution. Cog Ther Res 1978;2:255-264.
39. Drossman DA, Thompson WG, Talley NJ. Identification of sub-groups of functional gastrointestinal disorders. Gastroenterol Int 1990;3:159-172.
40. Weitzenoffer AM. The production of hypnotic phenomena. In: Weitzenhoffer AM. The Practice of Hypnotism. 2nd ed. New York: John Wiley & Sons, 2000.
41. Kazdin AE, Wilson GT. Criteria for evaluating psychotherapy. Arch Gen Psychiatry 1978;35:407-416.
42. Creed F, Guthrie E. The difficult patient: treating the mind and the gut. Eur J Gastroenterol Hepatol 1994;6:489-494.
43. Creed F, Guthrie E. Psychological treatments of the irritable bowel syndrome: A review. Gut 1989;30:1601-1609.
44. Whorwell PJ. Use of hypnotherapy in gastrointestinal disease. Br J Hosp Med 1991;45:27-29.
45. Read NW. Harnessing the patient's powers of recovery: The role of the psychotherapies in the irritable bowel syndrome. Baillieres Best Pract Res Clin Gastroenterol 1999;13:473-487.
46. Heap M, Arvind KK. Hypnotic susceptibility and its measurement. In: Hartland's Medical and Dental Hypnosis. Edinburgh: Churchill Livingstone, 2002.
47. Hilgard ER. The Stanford Hypnotic Susceptibility Scales as related to other measures of hypnotic responsiveness. Am J Clin Hypn 1978;21(2-3):68-83.
48. Angelini FJ, Kumar VK, Chandler L. The Harvard Group Scale of Hypnotic Susceptibility and related instruments: individual and group administrations. Int J Clin Exp Hypn 1999;47:236-250.